Carteolol is a non-selective beta-adrenergic blocker with intrinsic sympathomimetic activity, used both systemically for hypertension and as an ophthalmic solution for the management of glaucoma. Simson Pharma's Carteolol reference standard and impurities support stability-indicating testing across both formulation types.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Carteolol Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.